Drug recall · May 25, 2022
Trulicity recall
Why: TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80
- Lots / codes
Lot #: D484557A, Exp: 10/25/2023.
- Quantity
- 1 box
- Company
- Cardinal Health Inc., Dublin, OH
- Distribution
- NM only
- Initiated
- April 5, 2022 · Voluntary: Firm initiated
- Classified
- May 19, 2022
- Reported
- May 25, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Trulicity
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.